Teton Advisors’s Syneron Medical Ltd ELOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-130,049
Closed -$1.42M 440
2017
Q2
$1.42M Buy
130,049
+28,800
+28% +$316K 0.14% 177
2017
Q1
$1.07M Hold
101,249
0.11% 220
2016
Q4
$850K Hold
101,249
0.09% 246
2016
Q3
$725K Hold
101,249
0.06% 330
2016
Q2
$779K Hold
101,249
0.07% 322
2016
Q1
$740K Hold
101,249
0.07% 330
2015
Q4
$781K Hold
101,249
0.07% 331
2015
Q3
$724K Hold
101,249
0.05% 343
2015
Q2
$1.07M Hold
101,249
0.07% 301
2015
Q1
$1.25M Hold
101,249
0.09% 281
2014
Q4
$945K Hold
101,249
0.06% 324
2014
Q3
$1.01M Hold
101,249
0.07% 310
2014
Q2
$1.04M Buy
101,249
+6,249
+7% +$67.5K 0.07% 324
2014
Q1
$1.18M Hold
95,000
0.08% 297
2013
Q4
$1.17M Hold
95,000
0.08% 295
2013
Q3
$819K Hold
95,000
0.06% 326
2013
Q2
$827K Buy
+95,000
New +$849K 0.07% 306

Other funds holding ELOS

Teton Advisors's ELOS Position: Q3 2017 in Review

Teton Advisors sold out of Syneron Medical Ltd (ELOS) in Q3 2017, closing a stake of 130,049 shares — an estimated $1.42M sold.

Teton Advisors first reported a position in ELOS in Q2 2013 and held it in 17 quarters. The position peaked at $1.42M in Q2 2017. 4 funds tracked by Wall St. Rank hold ELOS as of Q3 2017.

  • Teton Advisors reported no remaining Syneron Medical Ltd position as of Q3 2017 after selling out during the quarter.
  • Teton Advisors sold 130,049 Syneron Medical Ltd shares in Q3 2017, an estimated $1.42M.
  • Teton Advisors first reported a position in Syneron Medical Ltd in Q2 2013 and held it in 17 quarters.
  • Teton Advisors's Syneron Medical Ltd position peaked at $1.42M in Q2 2017.
  • 4 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2017.

Based on Teton Advisors's 13F filing for Q3 2017, filed 1 Nov 2017.